Patients Discontinuing Anti-Obesity Medications Put On Pounds Far More Rapidly Than People Using Diet and Exercise

New research indicates that people who stop using new GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise regimens.

Published data in a prominent health publication points out that while overweight individuals can lose a large proportion of their total mass while on the medication, the mass is regained at an estimated rate of nearly a kilo each month once they quit.

"Users buying such medications need to be cognizant of the risk of fast rebound weight gain when the medication is stopped," stated expert Dr. Susan Jebb.

Such speed of regain means a reversion to starting weight in about 18 months.

Analyzing Therapies

The research, which examined 37 of studies involving thousands of participants, compared the outcomes of GLP-1 agonists with other pills.

The team point out that people who lose weight through lifestyle changes alone typically see a slower creep back—perhaps 100 grams monthly—after stopping.

Understanding the Quick Rebound

Nutrition scientists propose the mechanism of the drugs accounts for the accelerated weight return.

These medications imitate a natural hormone called GLP-1, which helps regulate feelings of fullness.

"Sustained high doses of GLP-1 concentrations far above than normal might result in the body to produce less of its endogenous hormone, and could lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher.

"Stopping of this GLP-1 'fix' leads to appetite is uncontrolled, making overeating a significant risk."

An Ongoing Condition?

Health authorities suggest the jabs for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.

A number of clinicians contend that, given the likelihood of weight regain, the treatment might need to be ongoing.

This opinion is reinforced by pharmaceutical companies, who note that the findings "underscore the persistent character of excess weight," akin to managing conditions like high blood pressure.

Patient Accounts

Users who have stopped the jabs explain a powerful return of cravings.

"I experienced something flipping and you become extremely hungry," described a patient.

The struggle is compounded if patients have not adopted sustainable dietary or behavioural modifications during treatment.

Significant Adoption

Figures show that a significant number of people in the UK have tried these injections in the last 12 months, with demand remaining high.

• Use is greater among women compared to men.
• The 40s and 50s age group shows the highest usage rates.
• Many obtain the drugs through private healthcare rather than public health services.

In conclusion, clinicians stress that while GLP-1 drugs are powerful agents for shedding pounds, they are not a magic cure and lasting health benefits hinges on ongoing lifestyle support.